Pharmacologic Inhibition of Ferroptosis Attenuates Experimental Abdominal Aortic Aneurysm Formation

Jonathan R Krebs,Paolo Bellotti,Jeff Arni C Valisno,Gang Su,Shiven Sharma,Denny Joseph M Kollareth,Joseph Hartman,Aravinthan Adithan,Michael Spinosa,Manasi Kamat,Timothy Garrett,Guoshuai Cai,Ashish K Sharma,Gilbert R Upchurch Jr.

DOI: https://doi.org/10.1101/2024.06.18.599427

2024-06-22

Abstract:The pathogenesis of abdominal aortic aneurysm (AAA) formation involves vascular inflammation, thrombosis formation and programmed cell death leading to aortic remodeling. Recent studies have suggested that ferroptosis, an excessive iron-mediated cell death, can regulate cardiovascular diseases, including AAAs. However, the role of ferroptosis in immune cells, like macrophages, and ferroptosis-related genes in AAA formation remains to be deciphered. Single cell-RNA sequencing of human aortic tissue from AAA patients demonstrates significant differences in ferroptosis-related genes compared to control aortic tissue. Using two established murine models of AAA and aortic rupture in C57BL/6 (WT) mice, we observed that treatment with liproxstatin-1, a specific ferroptosis inhibitor, significantly attenuated aortic diameter, pro-inflammatory cytokine production, immune cell infiltration (neutrophils and macrophages), increased smooth muscle cell α-actin expression and elastic fiber disruption compared to mice treated with inactivated elastase in both pre-treatment and treatment after a small AAA had already formed. Lipidomic analysis using mass spectrometry shows a significant increase in ceramides and a decrease in intact lipid species levels in murine tissue compared to controls in the chronic AAA model on day 28. Mechanistically, in vitro studies demonstrate that liproxstatin-1 treatment of macrophages mitigated the crosstalk with aortic smooth muscle cells (SMCs) by downregulating MMP2 secretion. Taken together, this study demonstrates that pharmacological inhibition by liproxstatin-1 mitigates macrophage-dependent ferroptosis contributing to inhibition of aortic inflammation and remodeling during AAA formation.

Immunology

What problem does this paper attempt to address?

The paper discusses the role of ferroptosis in the formation of Abdominal Aortic Aneurysm (AAA) and proposes that inhibiting ferroptosis with drugs can alleviate the development of AAA. The research team found significant differences in gene expression related to ferroptosis in human AAA tissue through single-cell RNA sequencing. They confirmed in a mouse model that the use of the ferroptosis inhibitor liproxstatin-1 can reduce AAA diameter, inflammatory cell infiltration, and elastic fiber damage, while increasing smooth muscle cell α-actin expression. Additionally, they found that liproxstatin-1 can reduce the production of pro-inflammatory cytokines, decrease lipid peroxidation, and enhance antioxidant levels. These results suggest that inhibiting ferroptosis can suppress immune cell-mediated inflammation and remodeling processes, thereby preventing the formation and growth of AAA.